VCI Wealth Management LLC Purchases 10,630 Shares of CVS Health Co. (NYSE:CVS)

VCI Wealth Management LLC lifted its stake in CVS Health Co. (NYSE:CVS - Free Report) by 52.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 30,885 shares of the pharmacy operator's stock after acquiring an additional 10,630 shares during the period. VCI Wealth Management LLC's holdings in CVS Health were worth $1,386,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health during the 3rd quarter worth about $25,000. Ridgewood Investments LLC increased its stake in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after acquiring an additional 450 shares during the period. Livelsberger Financial Advisory acquired a new position in CVS Health in the 3rd quarter valued at approximately $31,000. Legacy Investment Solutions LLC bought a new stake in shares of CVS Health in the 3rd quarter worth approximately $31,000. Finally, Reston Wealth Management LLC acquired a new stake in shares of CVS Health during the 3rd quarter worth approximately $32,000. Institutional investors own 80.66% of the company's stock.

Analyst Ratings Changes

CVS has been the subject of several research reports. Royal Bank of Canada reduced their target price on CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research report on Friday, November 15th. Evercore ISI raised their price objective on shares of CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a report on Monday. TD Cowen upped their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, November 25th. Truist Financial cut their price target on shares of CVS Health from $67.00 to $60.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Finally, Barclays lowered their price objective on CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research note on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have given a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $68.12.

CVS Health Price Performance

Shares of CVS traded up $1.25 during mid-day trading on Tuesday, hitting $57.45. 14,018,429 shares of the company traded hands, compared to its average volume of 13,772,261. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The business has a 50-day moving average of $51.24 and a 200 day moving average of $56.19. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The stock has a market capitalization of $72.29 billion, a price-to-earnings ratio of 14.58, a PEG ratio of 0.80 and a beta of 0.59.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm's quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.21 earnings per share. As a group, equities analysts expect that CVS Health Co. will post 5.22 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.63%. CVS Health's dividend payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.